Should major pharmaceutical firms be asked to offer drugs to the poorest countries at prices that cover only their costs, and provide no profit?
BACKGROUND: The New York Times reports that “two companies that make vaccines against cervical cancer announced Thursday that they would cut their prices to the world’s poorest countries below $5 per dose, eventually making it possible for millions of girls to be protected against a major deadly cancer.” See the full report here.
The vaccines typically costs about $130 per dose in the United States, the Times reports.
Please Note: The mission of The Global Conversation website is to generate an ongoing sharing of thoughts, ideas, and opinions at this internet location in an interchange that we hope will produce an ongoing and expanding conversation ultimately generating wider benefit for our world. For this reason, links that draw people away from this site will be removed from our Comments Section, a process which may delay publication of your post. If you wish to include in your Comment the point of view of someone other than yourself, please feel free to report those views in full (and even reprint them) here.
Click here to acknowledge and remove this note: